Biography
Dr. Xiao Hao is a distinguished Chief Oncologist at Xijing Hospital, Air Force Medical University with 17 years of dedicated clinical practice. Over the course of an extensive career, Xiao Hao has treated thousands of international and domestic patients, establishing a reputation for clinical excellence, evidence-based decision-making, and compassionate, family-centered care.
Clinical Focus & Expertise
Dr. Xiao Hao specializes in the diagnosis and management of complex medical conditions, with particular expertise in Stereotactic radiotherapy, CAR-T cell therapy, Immunotherapy, Targeted therapy, Colorectal cancer. The clinical practice combines current best-evidence medicine with personalized treatment planning — recognizing that every patient brings a unique medical history, lifestyle, and set of life priorities to the consultation room.
Conditions Treated
Patients consult Dr. Xiao Hao for the following conditions and procedures:
- Stereotactic radiotherapy
- CAR-T cell therapy
- Immunotherapy
- Targeted therapy
- Colorectal cancer
Education & Training
- MD Peking University Health Science Center · Visiting Scholar Royal Marsden Hospital
Professional Credentials & Memberships
- Chinese Society of Clinical Oncology Member
- International Association for the Study of Lung Cancer
- European Society for Medical Oncology (ESMO)
International Patient Care
Dr. Xiao Hao communicates with patients in English, Chinese, French, providing direct rapport without the need for translation in those languages. The hospital's international department coordinates dedicated case managers, multilingual interpreters for additional languages, simplified visa documentation, and personalized treatment itineraries for travelers from over 60 countries.
“Every patient deserves more than a diagnosis — they deserve a treatment plan that respects who they are, where they come from, and what matters most to them.”
Education
MD Peking University Health Science Center · Visiting Scholar Royal Marsden Hospital
Certifications
- Chinese Society of Clinical Oncology Member
- International Association for the Study of Lung Cancer
- European Society for Medical Oncology (ESMO)